Source comparison
Quickcomparison
Dose Range Pidotimod 400–800 mg Thymosin Alpha-1 1.6–3.2 mg Frequency Multiple times daily Twice weekly Administration Oral (tablet) Subcutaneous injection Cycle Length 12+ weeks 8-12 weeks Onset Speed Moderate (1-2 weeks) Evidence Level Moderate human trials
This comparison does not assign a generated winner or score.
- Dose Range
- Pidotimod
- 400–800 mg
- Thymosin Alpha-1
- 1.6–3.2 mg
- Frequency
- Multiple times daily
- Twice weekly
- Administration
- Oral (tablet)
- Subcutaneous injection
- Cycle Length
- 12+ weeks
- 8-12 weeks
- Onset Speed
- Moderate (1-2 weeks)
- Evidence Level
- Moderate human trials (Phase 1-2)
- Efficacy